TRCT
INBS icon

Tower Research Capital (TRC)’s Intelligent Bio Solutions INBS Stock Holding History

Tower Research Capital (TRC)’s Portfolio INBS Stock Details INBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.18K Sell
1,250
-10
-0.8% -$69 ﹤0.01% 4225
2025
Q4 		$12K Buy
+1,260
New +$10.3K ﹤0.01% 3524
2025
Q1 		– Sell
-580
Closed -$8.12K – 5483
2024
Q4 		$8.12K Buy
580
+474
+447% +$7.23K ﹤0.01% 4022
2024
Q3 		$1.84K Buy
106
+41
+63% +$639 ﹤0.01% 5097
2024
Q2 		$1.26K Sell
65
-40
-38% -$1.02K ﹤0.01% 5180
2024
Q1 		$4.43K Sell
105
-106
-50% -$4.39K ﹤0.01% 4681
2023
Q4 		$8.57K Buy
211
+161
+322% +$6.33K ﹤0.01% 4497
2023
Q3 		$6.12K Buy
50
+25
+100% +$5.67K ﹤0.01% 4641
2023
Q2 		$8.41K Buy
25
+1
+4% +$346 ﹤0.01% 4435
2023
Q1 		$8K Buy
+24
New +$22K ﹤0.01% 4635
2022
Q4 		– Hold
0
– – – 6126
2022
Q2 		– Sell
-2
Closed -$3K – 6279
2022
Q1 		$3K Hold
2
– – ﹤0.01% 5374
2021
Q4 		$8K Buy
2
+1
+100% +$4.59K ﹤0.01% 4791
2021
Q3 		$8K Hold
1
– – ﹤0.01% 4540
2021
Q2 		$14K Hold
1
– – ﹤0.01% 4177
2021
Q1 		$7K Buy
+1
New +$17.2K ﹤0.01% 4530

Other funds holding INBS

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
CW
Curio Wealth Annapolis, Maryland $293M AUM 14.23% 1-Year Est. Return

Tower Research Capital (TRC)'s INBS Position: Q1 2026 in Review

Tower Research Capital (TRC) reduced its Intelligent Bio Solutions (INBS) stake by 0.79% in Q1 2026, selling an estimated $69 and leaving 1,250 shares worth $4.18K. The position accounts for ﹤0.01% of the portfolio, ranked #4225.

Tower Research Capital (TRC) first reported a position in INBS in Q1 2021 and has held it in 15 quarters since. The position peaked at $14K in Q2 2021. 9 funds tracked by Wall St. Rank hold INBS as of Q1 2026.

  • Tower Research Capital (TRC) held 1,250 shares of Intelligent Bio Solutions worth $4.18K as of Q1 2026.
  • Tower Research Capital (TRC) sold 10 Intelligent Bio Solutions shares in Q1 2026, an estimated $69.
  • Intelligent Bio Solutions made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q1 2026, its #4225 holding.
  • Tower Research Capital (TRC) first reported a position in Intelligent Bio Solutions in Q1 2021 and has held it in 15 quarters since.
  • Tower Research Capital (TRC)'s Intelligent Bio Solutions position peaked at $14K in Q2 2021.
  • 9 funds tracked by Wall St. Rank held Intelligent Bio Solutions as of Q1 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2026, filed 15 May 2026.